Cara Therapeutics, Inc. (CARA) Social Stream



Cara Therapeutics, Inc. (CARA): $0.73

0.04 (-4.70%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add CARA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#235 of 358

in industry

CARA THERAPEUTICS INC (CARA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CARA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $35 $16 $26.125 $0.665 3828.57%
2021-11-28 8 $35 $17 $26.25 $0.665 3847.37%
2022-02-02 7 $35 $17.001 $26.25 $0.665 3847.37%
2022-03-02 8 $35 $15 $25.875 $0.665 3790.98%
2022-03-08 8 $35 $15 $26.25 $0.665 3847.37%
2022-04-06 8 $33 $15 $25.428 $0.665 3723.76%
2022-05-09 7 $33 $15 $25.428 $0.665 3723.76%
2022-05-16 7 $33 $13 $24.571 $0.665 3594.89%
2022-10-10 7 $33 $13 $24.714 $0.665 3616.39%
2023-02-09 6 $30 $13 $22.333 $0.665 3258.35%
2023-02-16 6 $28 $13 $21.5 $0.665 3133.08%
2023-03-07 6 $28 $13 $19.6 $0.665 2847.37%
2023-03-27 7 $28 $6 $18 $0.665 2606.77%
2023-05-15 8 $28 $6 $18.5 $0.665 2681.95%
2023-07-17 8 $28 $4 $17.625 $0.665 2550.38%
2023-08-07 8 $25 $4 $17.25 $0.665 2493.98%
2023-08-08 8 $25 $3.5 $17.062 $0.665 2465.71%
2023-08-09 8 $25 $3.5 $16.812 $0.665 2428.12%
2023-08-25 8 $25 $3 $16.75 $0.665 2418.8%
2023-09-07 8 $25 $3 $15.5 $0.665 2230.83%
2023-10-20 8 $25 $3 $14.5 $0.665 2080.45%
2023-11-02 8 $23 $3 $13.875 $0.665 1986.47%
2023-11-13 8 $23 $1 $12.5 $0.665 1779.7%
2023-11-14 7 $22 $1 $12.143 $0.665 1726.02%
2023-12-19 7 $22 $1 $10.071 $0.665 1414.44%

The Trend in the Analyst Price Target


Over the past 20 months, CARA's average price target has gone down $16.79.

CARA reports an average of 534.53% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 6 30 13.0 22.333 12.27 82.01%
2023-03-07 6 28 18.0 22.000 6.69 228.85%
2023-04-04 8 28 6.0 18.500 4.74 290.3%
2023-08-09 8 25 3.5 16.812 3.02 456.69%
2023-10-20 8 25 3.0 14.500 1.29 1024.03%

CARA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 5 1 1 0 0 7

The Trend in the Broker Recommendations


CARA's average broker recommendation rating improved by 0.32 over the prior 29 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, CARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3369.35% of them.
  • In the context of all US stocks, CARA THERAPEUTICS INC's variance in analysts' estimates is lower than -2814.27% of them.
  • In terms of how CARA THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2869.96% of that group.
  • In the context of Healthcare stocks, CARA THERAPEUTICS INC's average analyst price target is greater than 1156.02% of them.

In the Pharmaceutical Products industry, OCUL, ARDX, and ARCT are the three stocks most similar to CARA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for CARA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!